Takayuki Yamada

Takayuki Yamada

Auto-generated profile, based on publicly available information

Takayuki Yamada

Division of Nephrology, Omihachiman Community Medical Center, Omihachiman, Japan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Annals of Oncology
Verified
Journal Article
Closed access
HMH. Miyashita
H. Miyashita
TMT. Mikami
T. Mikami
NCN. Chopra
N. Chopra
TYT. Yamada
T. Yamada
SCS. Chernyavsky
S. Chernyavsky
CCC. Cruz
C. Cruz

1 October 2020 in Clinica Chimica Acta
Verified
Journal Article
Closed access
TYTakayuki Yamada
Takayuki Yamada
MWMako Wakabayashi
Mako Wakabayashi
TYTakahiro Yamaji
Takahiro Yamaji
NCNitin Chopra
Nitin Chopra
TMTakahisa Mikami
Takahisa Mikami
SMSatoshi Miyashita
Satoshi Miyashita

26 May 2020 in International Urology and Nephrology
Verified
Journal Article
Open access
PDF file
TYTakayuki Yamada
Takayuki Yamada
TMTakahisa Mikami
Takahisa Mikami
NCNitin Chopra
Nitin Chopra
HMHirotaka Miyashita
Hirotaka Miyashita
SCSvetlana Chernyavsky
Svetlana Chernyavsky
SMSatoshi Miyashita
Satoshi Miyashita

12 October 2023 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
STShunichiro Tsukamoto
Shunichiro Tsukamoto
STShohei Tanaka
Shohei Tanaka
TYTakayuki Yamada
Takayuki Yamada
KUKazushi Uneda
Kazushi Uneda
KAKengo Azushima
Kengo Azushima
KTKouichi Tamura
Kouichi Tamura

2 February 2023 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
RMRyutaro Morita
Ryutaro Morita
STShunichiro Tsukamoto
Shunichiro Tsukamoto
SOShota Obata
Shota Obata
TYTakayuki Yamada
Takayuki Yamada
KUKazushi Uneda
Kazushi Uneda
KTKouichi Tamura
Kouichi Tamura

18 July 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
AKArjun Lalit Kalaria
Arjun Lalit Kalaria
TYTakayuki Yamada
Takayuki Yamada
MKMichele Klein-Fedyshin
Michele Klein-Fedyshin
SOShota Obata
Shota Obata
MCMassiel Cruz-Peralta
Massiel Cruz-Peralta
RMRajil B Mehta
Rajil B Mehta
Introduction: Subclinical rejection (SCR) refers to the presence of acute rejection without accompanying kidney allograft dysfunction. The impact of SCR on long-term graft survival remains a subject of ongoing debate. Methods and analysis: We will perform a systematic search of databases including MEDLINE, Embase and Cochrane Central, from January 1995 to November 2023. We will include English-language studies involving adult kidney transplant patients who investigated SCR. We will exclude studies focused on ‘for-cause’ biopsies. Both title, abstract screening and full-text screening will be performed by two or more reviewers. The primary outcome of this study will be death-censored allograft loss. The secondary outcome will include development of subsequent rejection. For time-dependent outcomes, we will prioritise HRs and the 95% CIs. In cases where HRs are unavailable, we will calculate risk ratios based on the recorded events. The risk of bias will be assessed using the Cochrane Collaboration’s revised tool for assessing the risk of bias in randomised trials and the Newcastle-Ottawa scale for cohort studies. We will employ a random effects model. We will evaluate heterogeneity using the I 2 variable. We will assess publication bias by funnel plots, Begg and Mazumdar test, and Egger’s test. Ethics and dissemination: Ethics approval does not apply as no original data will be collected. The results will be disseminated through peer-reviewed publications and conference presentations. PROSPERO registration number: CRD42023463536.